Joanna R. M.
- Country
- Poland
- Department
- NA
Research Overview
- Evaluation of Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Amlitelimab in Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
- Evaluation of Subcutaneous Methotrexate Efficacy and Safety Compared to Placebo in Adults with Moderate to Severe Atopic Dermatitis
- Efficacy and Safety Evaluation of Rezpegaldesleukin in Biologic-Naive Adults with Moderate-to-Severe Atopic Dermatitis: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 160 of 386 partner sites.
Specializations
Psoriasis Research
This investigator demonstrates significant involvement in studying therapeutic approaches for moderate to severe plaque psoriasis. Their research encompasses evaluation of novel treatments including ESK-001 and BMS-986165, focusing on long-term safety and efficacy assessments.
- Plaque psoriasis management
- Long-term treatment safety
- Novel therapeutic agents
Atopic Dermatitis Studies
The investigator specializes in researching treatments for moderate to severe atopic dermatitis. Their work includes studies of various therapeutic approaches including methotrexate, amlitelimab, and rezpegaldesleukin.
- Biologic therapies
- Disease severity assessment
- Treatment durability
Additional Dermatological Conditions
The investigator's expertise extends to other dermatological conditions, including prurigo nodularis and chronic spontaneous urticaria. Their research encompasses evaluation of treatments such as nemolizumab for specific dermatological manifestations.
- Chronic urticaria management
- Prurigo nodularis treatment
- Treatment response assessment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.